This grant supports research focused on the clinical development and validation of predictive biomarkers for disease progression and treatment response in chronic non-communicable diseases (excluding cancer) using established AI methodologies. The aim is to combine data from clinically used and candidate biomarkers, along with clinical studies and Real-World Data, to enable timely and effective therapeutic interventions. The expected outcomes include the development of novel, clinically validated predictive biomarkers that improve patient outcomes, support personalised medicine, and provide healthcare professionals with trustworthy AI tools for decision support.
| Agency | HORIZON (EU) |
|---|---|
| Region | EU |
| Country | N/A |
| Legal form | Company, NGO, Government organization, Other |
| Start date | 10 Feb 2027 |
| End date | 13 Apr 2027 |
| Max funding | 6,000,000 – 8,000,000 EUR per grant |
| Budget | 44,200,000 EUR (2027 call budget for topic HORIZON-HLTH-2027-02-TOOL-01-two-stage) |
| Coverage | Union funding can be provided to entities established in EU Member States, Associated Countries, and, under certain provisions, the USA. Non-EU/non-Associated Countries may participate under specific conditions. Detailed eligibility and coverage conditions are outlined in the Horizon Europe Work Programme. |